Government Regulation and the Believability of Prescription Drug Advertising
- 1 June 1977
- journal article
- research article
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 11 (6) , 338-343
- https://doi.org/10.1177/106002807701100602
Abstract
An experimental study was undertaken to assess the impact of governmental regulation on the believability of prescription drug advertising. The specific variables investigated were symbolic impact and fair balance. Mock advertisements were developed for four tricyclic antidepressant drugs. Symbolic impact was operationalized by portraying the advertisements as originating from U.S. medical journals (i.e., regulated) or Mexican medical journals (i.e., unregulated). Fair balance was operationally defined as the inclusion of a brief summary in the advertisement. A nonrandom sample of twenty-four physicians saw four advertisements representing the four treatment combinations. On a self-administered questionnaire, they indicated their confidence in the information contained in the advertisement. A two-factor, repeated measures randomized block factorial design was employed in the analysis. The results indicated that the presence of fair balance was significantly associated with higher levels of believability; the symbolic impact factor was non-significantly associated with believability.Keywords
This publication has 4 references indexed in Scilit:
- Comments on "Attribution Theory and Advertiser Credibility"Journal of Marketing Research, 1976
- An attribution analysis of the effect of communicator characteristics on opinion change: The case of communicator attractiveness.Journal of Personality and Social Psychology, 1975
- An Advertiser's View of Drug AdvertisingJournal of Drug Issues, 1974
- Advertising: Informational but Not EducationalNew England Journal of Medicine, 1972